Aktie A185750 CHONG KUN DANG PHARMACEUTICAL CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Chong Kun Dang Pharmaceutical Corp.

Aktien

A185750

KR7185750007

A185750

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 26.04.2024 		% 5 Tage % 1. Jan.
101.100 KRW +0,50 % Intraday Chart für Chong Kun Dang Pharmaceutical Corp. +1,92 % -22,77 %
23.01. Chong Kun Dang Pharmaceutical Corp. (KOSE:A185750) kündigt einen Aktienrückkauf im Wert von 15.000 Millionen KRW an. CI
23.01. Chong Kun Dang Pharmaceutical Corp. genehmigt einen Rückkaufplan. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on January 23, 2024.
Chong Kun Dang Pharmaceutical Corp. announces an Equity Buyback for KRW 15,000 million worth of its shares.
Chong Kun Dang Pharmaceutical Corp. authorizes a Buyback Plan.
Chong Kun Dang Pharmaceutical Inks Largest-Ever Technology Transfer Agreement with Novartis
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback announced on October 13, 2022, has expired with 62,127 shares, representing 0.51% for KRW 4,856.39 million.
Chong Kun Dang Pharmaceutical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback announced on February 10, 2022, has expired with 109,064 shares, representing 0.89% for KRW 9,895.01 million.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A185750 Aktie
  4. Nachrichten Chong Kun Dang Pharmaceutical Corp.
  5. Andere Sprachen